SCHEMBL22702012

SCHEMBL22702012

O=C(O)/C=C/[S+]([O-])c1ccccc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
MAOB P27338 1/20 0.43
CYP1A2 P05177 2/20 0.42
ALDH1A1 P00352 3/20 0.42
POLB P06746 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
GPR35 Q9HC97 1/20 0.38
TSHR P16473 2/20 0.37
CTSD P07339 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9330870 0.72 HCAR2 (0.43) MAPTCYP1A2ALDH1A1POLBCYP2C9
SCHEMBL9845672 0.72 HCAR2 (0.43) MAPTCYP1A2ALDH1A1POLBCYP2C9
SCHEMBL9845559 0.72 HCAR2 (0.43) MAPTCYP1A2ALDH1A1POLBCYP2C9
SCHEMBL2461936 0.72 HSD17B10 (0.50) CYP1A2ALDH1A1MEN1KMT2ANPC1
Crotonic Acid SCHEMBL27807284 0.71 MAPT (0.62) MAPTMAOBCYP1A2ALDH1A1POLB
Crotonic Acid SCHEMBL27983318 0.71 MAPT (0.62) MAPTMAOBCYP1A2ALDH1A1POLB
SCHEMBL42323 0.70 MAPT (1.00) MAPTMAOBALDH1A1MEN1KMT2A
SCHEMBL10673342 0.70 MAPT (1.00) MAPTMAOBALDH1A1MEN1KMT2A
SCHEMBL820084 0.70 MAPT (1.00) MAPTMAOBALDH1A1MEN1KMT2A
SCHEMBL3295983 0.70 MAPT (1.00) MAPTMAOBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3411361-B1 NRF2 ACTIVATING COMPOUNDS AND USES THEREOF RIGEL PHARMACEUTICALS INC (US) 2020-11-25 EP disclosed